Company / Operating Income
Minerva Neurosciences, Inc. Operating Income History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$21.8M
FY2024
5-year range
-$75.9M / $1.8M
FY2020-FY2024
Trend
+13.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 8 years, ranging from -$76M in FY2020 to $2M in FY2021.
Based on SEC 10-K filings.
-$22M in FY2024.
Improved from -$45M to -$22M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income increased 13.4% year-over-year.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$21.8M | +13.4% |
| FY2023 | -$25.2M | +44.4% |
| FY2022 | -$45.4M | -2556.5% |
| FY2021 | $1.8M | +102.4% |
| FY2020 | -$75.9M | -46.7% |
| FY2019 | -$51.7M | -25.6% |
| FY2018 | -$41.2M | -57.7% |
| FY2017 | -$26.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026